Flying Penguins

The Case for Indie Drugs

The uncomfortable truth about our Ozempic obsession

Jul 1 • 

Joey DeBruin

3

April 2025

March 2025

Leeches, Cancer Abstracts, and Coming Home

Why now is the time to pursue problems you genuinely care about. Also, we’re hiring.

Mar 10 • 

Joey DeBruin

2

February 2025

AI Will Make Cold Outreach More Valuable, Not Less

The counterintuitive case for investing in outreach automation

Feb 25 • 

Joey DeBruin

Where the AI-as-Employee Model Breaks

Agents don't onboard like humans, and that's a good thing for niche industries

Feb 19 • 

Joey DeBruin

4

Will AI make science's reproducibility crisis worse?

Obviously — but is there room for optimism in the long run?

Feb 5 • 

Joey DeBruin

1

2

January 2025

How We’re Speedrunning Biotech Market Research with AI

A peek under the hood at the workflows we use to map a complex industry

Jan 28 • 

Joey DeBruin

5

Build a Stylesheet to Make AI Actually Sound Like You

A simple hack to create consistent, authentic AI content (and a free tool to generate one from any Substack)

Jan 22 • 

Joey DeBruin

5

The Opportunity for AI in Science Isn’t Where You Think

It’s finally time for bio tech

Jan 15 • 

Joey DeBruin

3

Software is Cheap. Clear problems aren’t.

On roboagencies and our bet on biotech

Jan 7 • 

Joey DeBruin

1

December 2024

What happens when software gets 100X cheaper?

The end of tech debt (and other predictions)

Dec 17, 2024 • 

Joey DeBruin

3

Don't build another AI app

Build an AI interface (in a few days)

Dec 10, 2024 • 

Joey DeBruin

4